Factors influencing treatment escalation from long-acting muscarinic antagonist monotherapy to triple therapy in patients with COPD: a retrospective THIN-database analysis

Factors influencing treatment escalation from long-acting muscarinic antagonist monotherapy to triple therapy in patients with COPD: a retrospective THIN-database analysis

John R Hurst,1 Maria Dilleen,2 Kevin Morris,3 Siân Hills,3 Birol Emir,4 Rupert Jones5 1UCL Respiratory, University College London, London, UK; 2Statistics, Global Product Development, Pfizer, Tadworth, UK; 3Medical Affairs, Pfizer, Tadworth, UK; 4Biostatistics, Global Product Development,...

Full description

Bibliographic Details
Main Authors: Hurst JR, Dilleen M, Morris K, Hills S, Emir B, Jones R
Format: Article
Language:English
Published: Dove Medical Press 2018-03-01
Series:International Journal of COPD
Subjects:
inhaled corticosteroid
treatment step-up
GOLD 2017 grouping
patient over-treatment
Online Access:https://www.dovepress.com/factors-influencing-treatment-escalation-from-long-acting-muscarinic-a-peer-reviewed-article-COPD

Internet

https://www.dovepress.com/factors-influencing-treatment-escalation-from-long-acting-muscarinic-a-peer-reviewed-article-COPD

Similar Items